o2h Discovery recognised as the ‘Best Industry Support Partner of the Year’ at the OBN Awards 2025

We are pleased to share that o2h Discovery has been recognised as the ‘Best Industry Support Partner of the Year’ at the OBN Awards 2025. This achievement reflects the dedication of our exceptional teams and the strong, collaborative partnerships we have built with various innovative biotech and pharma organisations worldwide.

This award follows our 2023 ‘Most Impactful CRO Award’ and holds special significance for us. It also showcases the steady progress we’ve made in enabling partners to advance their discovery programmes, strengthened by long-standing relationships and shared achievements over the years.

Adding to this moment, Prashant Shah, CEO, o2h Discovery, shared:

At o2h, we love seeding new ideas in life sciences and are delighted to receive this award for our role as an industry support partner in the life sciences ecosystem. Our work cuts across investment, co-discovery models and incubation. We are lucky enough to work in the life-sciences ecosystem which truly has a collaborative culture and ethos. The sector is full of mission driven people who think about the greater endeavour they are part of beyond themselves. Thank you to the OBN team and judges for this recognition.

Last year we launched the first life sciences week for Cambridge, called the Cambridge Wide Open Week, now nicknamed CWOW. We look forward to extending CWOW to Oxford and London, as we reframe CWOW to combined ways of working…

Stuart Rose, CEO, OBN, reflected on this years’ awards programme:

We extend our warmest congratulations to all of last night’s finalists and winners; achievements which reflect leadership and determination, both qualities that are driving the development of exceptional innovation, advancing research, and shaping the future of treatments and diagnostics to improve patient outcomes. Last night was a wonderful opportunity to say that what you do truly makes a difference, and on behalf of the whole OBN community, we offer our sincere thanks.

About the OBN Awards:

The OBN Awards celebrate outstanding innovation, leadership, and scientific progress within the life sciences sector. Each year, the programme highlights organisations and individuals delivering real-world impact through science, novel approaches to unmet clinical needs, and measurable advancement. The 2025 edition features 12 categories spanning Biotech, Medtech, and Digital Health, recognising achievements from emerging R&D teams to established pharma and life sciences investors.

Click here to learn more about OBN Awards.

About the “Best Industry Support Partner of the Year” category:

This category honours organisations that deliver exceptional scientific, operational, and ecosystem support to early-stage and scaling life science companies. The Evaluation process for this esteemed category took into consideration various aspects, including :

• Support Model: How effectively the organisation drives biotech programs through integrated chemistry, biology, and development support.
• Differentiation: The specialised capabilities and strengths that set the organisation apart.
• Partner Impact: Measurable milestones enabled for partners, backed by their feedback.
• Team Strength: Expertise and reliability of the scientific and leadership teams.
• ESG Priorities: Adoption of responsible environmental, social, and governance practices.
• Overall Contribution: The organisation’s broader impact on supporting and strengthening the biotech ecosystem.

About o2h Discovery

Founded in 2005, o2h Discovery has a multi-modality integrated drug discovery platform, operating from its state-of-the-art research centres in Cambridge, UK, and Ahmedabad, India. We execute hit-to-lead optimisation programmes leading into patent and IND filing, with deep expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.

We have experienced scientists who deliver a comprehensive range of custom peptide synthesis services, from small quantities of a few milligrams to larger amounts at the gram scale. Our capabilities go beyond standard fast custom peptide synthesis services (o2h Peptide Guarantee), offering specialised peptide modification services to customise and optimise peptides for diverse drug discovery programs. Our clients include large pharma companies, leading academic institutions, and biotech firms.

o2h Discovery’s large team of experts also delivers high-quality services, covering DMPK, scale-up/PR&D, PROTAC’s (Protac Synthesis Services), LNPs, various assays, including ChamelogK, supporting organisations of all sizes with cost-effective solutions from target validation all the way to IND-enabling studies.

The DNA of o2h Discovery is centred around the nurturing of its people, values, and culture. It reflects in the way we work with each other, as well as our collaborators and partners.

For further information or to explore collaboration opportunities, feel free to reach out to us at discovery@o2h.com.